| |
 |
|
Class Information
Number: 424/269.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Parasitic organism or component thereof or substance produced by said parasitic organism (e.g., schistosoma, dirofilaria, trichinella, fasciola, ancylostoma, ascaris, etc.) > Parasitic protozoan (e.g., trypanosoma, trichomonas, leishmania, entamoeba, etc.)
Description: Subject matter wherein the parasitic organism is a parasitic protozoan.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7419668 |
Vaccine to control equine protozoal myeloencephalitis in horses |
Sep. 2, 2008 |
| 7361359 |
Neospora caninum isolate |
Apr. 22, 2008 |
| 7282210 |
Process for the in vitro culture of different stages of tissular parasites |
Oct. 16, 2007 |
| 7273709 |
Detection of sarcocystis neurona |
Sep. 25, 2007 |
| 7250173 |
Use of parasitic biological agents for prevention and control of autoimmune diseases |
Jul. 31, 2007 |
| 7238347 |
Suicidal mutant Leishmania vaccine |
Jul. 3, 2007 |
| 7189399 |
Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful for serologic diagnosis of canine leishmaniosis and protein obtained |
Mar. 13, 2007 |
| 7179615 |
Method of prophylaxis and treatment |
Feb. 20, 2007 |
| 7169398 |
Equine protozoal myeloencephalitis vaccine |
Jan. 30, 2007 |
| 7150873 |
Coccidiosis vaccines |
Dec. 19, 2006 |
| 7141245 |
Process for preparation of a microbial agent |
Nov. 28, 2006 |
| 7094576 |
Methods and compositions for detecting larval Taenia solium with a cloned diagnostic antigen |
Aug. 22, 2006 |
| 7078044 |
Anti-amoebic vaccine |
Jul. 18, 2006 |
| 7071296 |
Plasmodium falciparum antigens inducing protective antibodies |
Jul. 4, 2006 |
| 7067315 |
Identification of anti-protozoal agents |
Jun. 27, 2006 |
| 7063848 |
Lipoglycan compositions and methods of treating parasitic infections |
Jun. 20, 2006 |
| 7022511 |
Process for the isolation and acclimatization of bacteria for lignin degradation |
Apr. 4, 2006 |
| 7018640 |
In ovo vaccination against coccidiosis |
Mar. 28, 2006 |
| 7008774 |
Practical serological assay for the clinical diagnosis of leishmaniasis |
Mar. 7, 2006 |
| 6998126 |
Selection of poultry Eimeria strains through extra-intestinal sporozoites |
Feb. 14, 2006 |
| 6994861 |
Attenuated live neospora vaccine |
Feb. 7, 2006 |
| 6962704 |
CHIMERIC GENE FORMED BY THE DNA SEQUENCES THAT ENCODE THE ANTIGENIC DETERMINANTS OF FOUR PROTEINS OF L. INFANTUM AND PROTEIN ENCODED BY SAID GENE, AND PHARMACEUTICAL COMPOSITION USEFUL FOR PRE |
Nov. 8, 2005 |
| 6936263 |
Th1 inducing natural adjuvant for heterologous antigens |
Aug. 30, 2005 |
| 6929795 |
Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful for serologic diagnosis of canine leishmaniosis and protein obtained |
Aug. 16, 2005 |
| 6890527 |
Methods of treatment |
May. 10, 2005 |
| 6891024 |
Monoclonal antibodies to Sarcocystis neurona and uses therefor |
May. 10, 2005 |
| 6890542 |
Leishmania vaccine |
May. 10, 2005 |
| 6855537 |
Macrophage-infecting parasites expressing a granulocyte macrophage colony stimulated factor |
Feb. 15, 2005 |
| 6808714 |
Detection of sarcocystis neurona |
Oct. 26, 2004 |
| 6787146 |
Neospora vaccine |
Sep. 7, 2004 |
| 6783765 |
Process for the preparation of a vaccine for the treatment of tuberculosis and other intracellular infections diseases and the vaccine produced by the process |
Aug. 31, 2004 |
| 6780415 |
Animal model for infection by an apicomplexan parasite |
Aug. 24, 2004 |
| 6756043 |
Compositions and methods for detecting adult Taenia solium |
Jun. 29, 2004 |
| 6730307 |
Anti-cryptosporidium parvum preparations |
May. 4, 2004 |
| 6709661 |
Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
Mar. 23, 2004 |
| 6710166 |
41 kDa Cryptosporidium parvum oocyst wall protein |
Mar. 23, 2004 |
| 6682746 |
Adjuvanted vaccine which is substantially free of non-host albumin |
Jan. 27, 2004 |
| 6680061 |
Coccidiosis vaccines |
Jan. 20, 2004 |
| 6673351 |
Compositions and methods for the treatment and clinical remission of psoriasis |
Jan. 6, 2004 |
| 6660840 |
Methods for enhancement of protective immune responses |
Dec. 9, 2003 |
| 6656479 |
Attenuated live neospora vaccine |
Dec. 2, 2003 |
| 6652847 |
Attenuated strains of leishmania and uses thereof |
Nov. 25, 2003 |
| 6638517 |
Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
Oct. 28, 2003 |
| 6613337 |
Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
Sep. 2, 2003 |
| 6607731 |
Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
Aug. 19, 2003 |
| 6525186 |
Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful of serologic diagnosis of canine leishmaniosis and protein obtained |
Feb. 25, 2003 |
| 6521229 |
41 kDa Cryptosporidium parvum oocyst wall protein |
Feb. 18, 2003 |
| 6500437 |
Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
Dec. 31, 2002 |
| 6500438 |
In ovo vaccination against coccidiosis |
Dec. 31, 2002 |
| 6491920 |
Polypeptides and DNA encoding same |
Dec. 10, 2002 |
|
|
|
